Related Experiment Video
Updated: Feb 25, 2026

Author Spotlight: Advancing Spectral Characterization of Physiological and Malperfused Tissues
Published on: July 5, 2024
Diabetes and Cardioplegia
Brittany A Potz1, Laura A Scrimgeour1, Jun Feng1
1Alpert Warren Medical School of Brown University, 2 Dudley Street, MOC 360, Providence, RI 02905, USA.
Insights
Cardiac surgery impairs blood vessels, especially in diabetic patients. Gene expression differences highlight potential targets for treating cardiovascular dysfunction in diabetes.
Area of Science:
- Cardiovascular Science
- Diabetic Complications
- Molecular Biology
Background:
- Cardiac surgery using cardiopulmonary bypass and cardioplegia can cause vascular and microcirculatory injury.
- Poorly controlled diabetes exacerbates these injuries, leading to endothelial dysfunction, altered vascular reactivity, and impaired cardiac function.
Purpose of the Study:
- To investigate the impact of diabetes on gene expression profiles following cardiac surgery with cardiopulmonary bypass and cardioplegic arrest.
- To identify potential medical targets by analyzing differential gene expression between diabetic and non-diabetic patients.
Main Methods:
- Comparative analysis of gene expression profiles in patients with and without diabetes undergoing cardiac surgery.
- Focus on differences in vascular dysfunction, permeability, protein expression, and microcirculation.
Main Results:
- Gene expression profiles post-cardiac surgery differ significantly in diabetic patients compared to non-diabetic patients.
- Diabetes is associated with pronounced endothelium-dependent and independent vascular dysfunction, altered vascular reactivity, and reduced vasomotor tone.
Conclusions:
- Diabetes significantly alters the molecular response to cardiopulmonary bypass and cardioplegic arrest.
- Gene expression profiling offers a promising avenue for identifying novel therapeutic targets to mitigate cardiac dysfunction in diabetic patients undergoing cardiac surgery.
Abstract:
Cardiac surgery with cardiopulmonary bypass and cardioplegic arrest is associated with injury to the vasculature and microcirculation leading to coronary microvascular dysfunction, permeability changes and cardiac dysfunction. In the setting of cardiopulmonary bypass with cardioplegia, poorly-controlled diabetes is associated with significant changes in endothelium-dependent and independent vascular dysfunction, vascular reactivity, vascular permeability, protein expression, cell death, coronary/peripheral microcirculation and reduced vasomotor tone leading to hypotension and impaired endothelial function. The gene expression profiles after cardiopulmonary bypass with cardioplegic arrest is quantitatively and qualitatively different in patients with diabetes. Gene expression profiling capitalizing on the differences between patients with and without diabetes is a good place to identify potential medical targets.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications
Hypoglycemia and Glucagon

